InvestorsHub Logo
Followers 39
Posts 1575
Boards Moderated 0
Alias Born 02/26/2013

Re: relyts post# 40632

Tuesday, 02/26/2013 8:38:41 PM

Tuesday, February 26, 2013 8:38:41 PM

Post# of 158400
Hi All,

Relyts---Love your DD
Paris---Suck an egg!


Didn't BMSN ($$$$$$$$$ (Regen BIOPharma)just enter into an LOI with Dendreon for provenge? to purchase patented intellectual property covering a novel means of treating breast cancer by augmenting the immune system using a "gene silencing" approach.

Dendreon expects Provenge to grow year-over-year in 2013
Dendreon said last night in its earnings call presentation slides that it believes Provenge will grow year-over-year in 2013. The company said that when its restructuring is complete, it believes cost of goods sold will be at less than 50% beginning in Q3. Dendreon expects to run U.S. operations for Provenge at cash flow positive at a net sales level of around $100M per quarter. The company expects a regulatory decision in Europe in mid-2013 and said its research indicates there is a significant need to educate the consumer. Further, Dendreon gas plans to commence enzalutamide sequencing trial as well as an early scanning registry.


http://www.theflyonthewall.com/permalinks/entry.php/DNDNid1791907/DNDN-Dendreon-expects-Provenge-to-grow-yearoveryear-in-


http://www.dendreon.com/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.